Global Pharmaceuticals & Biotech Sustainable Track Record

PharmaEngine

Market Cap: NT$10.1b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Niagen Bioscience

Market Cap: US$549.4m

Operates as a bioscience company engages in developing healthy aging products.

Ever Supreme Bio Technology

Market Cap: NT$14.4b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Memphis Pharmaceuticals & Chemical Industries

Market Cap: ج.م4.1b

A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

CytomX Therapeutics

Market Cap: US$620.1m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Merck

Market Cap: US$239.3b

Operates as a healthcare company worldwide.

Consun Pharmaceutical Group

Market Cap: HK$12.0b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

AGP

Market Cap: PK₨51.9b

Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.

JW Lifescience

Market Cap: ₩231.6b

Provides national infusion solutions in South Korea and internationally.

Genmab

Market Cap: DKK 121.8b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Incyte

Market Cap: US$20.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.5b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

TTY Biopharm

Market Cap: NT$19.5b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

Shandong Wit Dyne HealthLtd

Market Cap: CN¥8.1b

Engages in the pharmaceutical business in China.

Harmony Biosciences Holdings

Market Cap: US$2.0b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Lupin

Market Cap: ₹925.0b

Operates as a pharmaceutical company in India, the United States, and internationally.

Hoechst Pakistan

Market Cap: PK₨40.6b

Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥17.7b

Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.

WuXi AppTec

Market Cap: CN¥277.4b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Alexandria For Pharmaceuticals & Chemical Industries

Market Cap: ج.م4.0b

Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.

ChemoMetec

Market Cap: DKK 13.1b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹426.6b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.3t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

L&C BIOLTD

Market Cap: ₩1.3t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

Kahira Pharmaceuticals & Chemical Industries

Market Cap: ج.م3.9b

Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.

Fidson Healthcare

Market Cap: ₦91.8b

Manufactures and distributes pharmaceutical products in Nigeria.

Medpace Holdings

Market Cap: US$16.6b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Exelixis

Market Cap: US$11.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

ADMA Biologics

Market Cap: US$3.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ACADIA Pharmaceuticals

Market Cap: US$4.0b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

AstraZeneca

Market Cap: UK£210.8b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

HBM Holdings

Market Cap: HK$12.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

Jagsonpal Pharmaceuticals

Market Cap: ₹14.0b

Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.

Henan Lingrui Pharmaceutical

Market Cap: CN¥12.5b

Produces and sells medicines in China.

BioSyent

Market Cap: CA$121.2m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Puma Biotechnology

Market Cap: US$255.0m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.